Variant report
Variant | esv3466093 |
---|---|
Chromosome Location | chr4:120244543-120244911 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs61574855 | chr4:120244573-120244574 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs199908041 | chr4:120244574-120244575 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs55884612 | chr4:120244577-120244578 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs373735748 | chr4:120244580-120244581 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs551456126 | chr4:120244581-120244582 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs376380126 | chr4:120244583-120244584 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs371070337 | chr4:120244588-120244589 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs375114344 | chr4:120244591-120244592 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs368454714 | chr4:120244592-120244593 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs540178512 | chr4:120244604-120244605 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs372310680 | chr4:120244605-120244606 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs190439776 | chr4:120244620-120244621 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs180882068 | chr4:120244626-120244627 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs186236136 | chr4:120244629-120244630 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs56166638 | chr4:120244648-120244649 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs571209051 | chr4:120244662-120244663 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs35917388 | chr4:120244663-120244664 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs181297399 | chr4:120244685-120244686 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs543587062 | chr4:120244698-120244699 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs567881780 | chr4:120244719-120244720 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs112016690 | chr4:120244724-120244725 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs59036484 | chr4:120244749-120244750 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs556936836 | chr4:120244781-120244782 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs2389746 | chr4:120244850-120244851 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs202156486 | chr4:120244856-120244857 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs376332368 | chr4:120244872-120244873 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs369906708 | chr4:120244886-120244887 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs141105010 | chr4:120244893-120244894 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs71627784 | chr4:120244902-120244903 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:120222000-120251000 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
2 | chr4:120222200-120244600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr4:120235600-120251000 | Weak transcription | Left Ventricle | heart |
4 | chr4:120243600-120245200 | Enhancers | Fetal Intestine Large | intestine |
5 | chr4:120244000-120245400 | Enhancers | Fetal Intestine Small | intestine |
6 | chr4:120244400-120244800 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
7 | chr4:120244400-120249800 | Weak transcription | Duodenum Mucosa | Duodenum |
8 | chr4:120244800-120245200 | Enhancers | Rectal Mucosa Donor 31 | rectum |